1h Free Analyst Time
The global vaccines market is forecasted to grow by USD 43.23 billion during 2025-2030, accelerating at a CAGR of 7.2% during the forecast period. The report on the global vaccines market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by expansion of public health initiatives and national immunization programs, technological advancements in vaccine platforms and manufacturing scalability, rising global emphasis on preventive healthcare and pandemic preparedness.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The global vaccines market is segmented as below:
By Type
- Subunit vaccines
- Live attenuated vaccines
- Inactivated vaccines
- Toxoid vaccines
- Others
By End-User
- Hospitals
- Clinics
By Technology
- mRNA vaccines
- Viral vector vaccines
- Protein based vaccines
- DNA vaccines
- Others
By Route Of Administration
- Intramuscular
- Subcutaneous
- Oral
- Intranasal
- Others
By Disease Type
- Influenza
- Human papillomavirus
- Hepatitis
- Measles
- Others
By Age Group
- Pediatric
- Adult
- Adolescent
- Geriatric
By Region
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Spain
- Asia
- Rest of World (ROW)
- Rest of World (ROW)
The report on the global vaccines market covers the following areas:
- Global vaccines market sizing
- Global vaccines market forecast
- Global vaccines market industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Market Segmentation by Technology
- Executive Summary - Chart on Market Segmentation by Route of Administration
- Executive Summary - Chart on Market Segmentation by Disease Type
- Executive Summary - Chart on Market Segmentation by Age Group
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Chart on Overview on criticality of inputs and factors of differentiation
- Chart on Overview on factors of disruption
- Chart on Impact of drivers and challenges in 2025 and 2030
3 Market Landscape
3.1 Market ecosystem
- Chart on Parent Market
- Data Table on - Parent Market
- Chart on Market characteristics analysis
- Chart on Value chain analysis
4 Market Sizing
4.1 Market definition
4.4 Market outlook: Forecast for 2025-2030
- Data Table on Offerings of companies included in the market definition
- Market segments
4.4 Market outlook: Forecast for 2025-2030
- Chart on Global - Market size and forecast 2025-2030 ($ million)
- Data Table on Global - Market size and forecast 2025-2030 ($ million)
- Chart on Global Market: Year-over-year growth 2025-2030 (%)
- Data Table on Global Market: Year-over-year growth 2025-2030 (%)
5 Historic Market Size
5.1 Global Vaccines Market 2020 - 2024
- Historic Market Size - Data Table on Global Vaccines Market 2020 - 2024 ($ million)
- Historic Market Size - Type Segment 2020 - 2024 ($ million)
- Historic Market Size - End-user Segment 2020 - 2024 ($ million)
- Historic Market Size - Technology Segment 2020 - 2024 ($ million)
- Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million)
- Historic Market Size - Disease Type Segment 2020 - 2024 ($ million)
- Historic Market Size - Age Group Segment 2020 - 2024 ($ million)
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
6.1 Impact of AI on global vaccines market
6.2 Impact of geopolitical conflicts on global vaccines market
6.2 Impact of geopolitical conflicts on global vaccines market
7 Five Forces Analysis
7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- Threat of new entrants - Impact of key factors in 2025 and 2030
- Threat of substitutes - Impact of key factors in 2025 and 2030
- Threat of rivalry - Impact of key factors in 2025 and 2030
- Chart on Market condition - Five forces 2025 and 2030
8 Market Segmentation by Type
8.1 Market segments
- Chart on Type - Market share 2025-2030 (%)
- Data Table on Type - Market share 2025-2030 (%)
- Chart on Comparison by Type
- Data Table on Comparison by Type
- Chart on Subunit vaccines - Market size and forecast 2025-2030 ($ million)
- Data Table on Subunit vaccines - Market size and forecast 2025-2030 ($ million)
- Chart on Subunit vaccines - Year-over-year growth 2025-2030 (%)
- Data Table on Subunit vaccines - Year-over-year growth 2025-2030 (%)
- Chart on Live attenuated vaccines - Market size and forecast 2025-2030 ($ million)
- Data Table on Live attenuated vaccines - Market size and forecast 2025-2030 ($ million)
- Chart on Live attenuated vaccines - Year-over-year growth 2025-2030 (%)
- Data Table on Live attenuated vaccines - Year-over-year growth 2025-2030 (%)
- Chart on Inactivated vaccines - Market size and forecast 2025-2030 ($ million)
- Data Table on Inactivated vaccines - Market size and forecast 2025-2030 ($ million)
- Chart on Inactivated vaccines - Year-over-year growth 2025-2030 (%)
- Data Table on Inactivated vaccines - Year-over-year growth 2025-2030 (%)
- Chart on Toxoid vaccines - Market size and forecast 2025-2030 ($ million)
- Data Table on Toxoid vaccines - Market size and forecast 2025-2030 ($ million)
- Chart on Toxoid vaccines - Year-over-year growth 2025-2030 (%)
- Data Table on Toxoid vaccines - Year-over-year growth 2025-2030 (%)
- Chart on Others - Market size and forecast 2025-2030 ($ million)
- Data Table on Others - Market size and forecast 2025-2030 ($ million)
- Chart on Others - Year-over-year growth 2025-2030 (%)
- Data Table on Others - Year-over-year growth 2025-2030 (%)
- Market opportunity by Type ($ million)
- Data Table on Market opportunity by Type ($ million)
9 Market Segmentation by End-user
9.1 Market segments
- Chart on End-user - Market share 2025-2030 (%)
- Data Table on End-user - Market share 2025-2030 (%)
- Chart on Comparison by End-user
- Data Table on Comparison by End-user
- Chart on Hospitals - Market size and forecast 2025-2030 ($ million)
- Data Table on Hospitals - Market size and forecast 2025-2030 ($ million)
- Chart on Hospitals - Year-over-year growth 2025-2030 (%)
- Data Table on Hospitals - Year-over-year growth 2025-2030 (%)
- Chart on Clinics - Market size and forecast 2025-2030 ($ million)
- Data Table on Clinics - Market size and forecast 2025-2030 ($ million)
- Chart on Clinics - Year-over-year growth 2025-2030 (%)
- Data Table on Clinics - Year-over-year growth 2025-2030 (%)
- Market opportunity by End-user ($ million)
- Data Table on Market opportunity by End-user ($ million)
10 Market Segmentation by Technology
10.1 Market segments
- Chart on Technology - Market share 2025-2030 (%)
- Data Table on Technology - Market share 2025-2030 (%)
- Chart on Comparison by Technology
- Data Table on Comparison by Technology
- Chart on mRNA vaccines - Market size and forecast 2025-2030 ($ million)
- Data Table on mRNA vaccines - Market size and forecast 2025-2030 ($ million)
- Chart on mRNA vaccines - Year-over-year growth 2025-2030 (%)
- Data Table on mRNA vaccines - Year-over-year growth 2025-2030 (%)
- Chart on Viral vector vaccines - Market size and forecast 2025-2030 ($ million)
- Data Table on Viral vector vaccines - Market size and forecast 2025-2030 ($ million)
- Chart on Viral vector vaccines - Year-over-year growth 2025-2030 (%)
- Data Table on Viral vector vaccines - Year-over-year growth 2025-2030 (%)
- Chart on Protein based vaccines - Market size and forecast 2025-2030 ($ million)
- Data Table on Protein based vaccines - Market size and forecast 2025-2030 ($ million)
- Chart on Protein based vaccines - Year-over-year growth 2025-2030 (%)
- Data Table on Protein based vaccines - Year-over-year growth 2025-2030 (%)
- Chart on DNA vaccines - Market size and forecast 2025-2030 ($ million)
- Data Table on DNA vaccines - Market size and forecast 2025-2030 ($ million)
- Chart on DNA vaccines - Year-over-year growth 2025-2030 (%)
- Data Table on DNA vaccines - Year-over-year growth 2025-2030 (%)
- Chart on Others - Market size and forecast 2025-2030 ($ million)
- Data Table on Others - Market size and forecast 2025-2030 ($ million)
- Chart on Others - Year-over-year growth 2025-2030 (%)
- Data Table on Others - Year-over-year growth 2025-2030 (%)
- Market opportunity by Technology ($ million)
- Data Table on Market opportunity by Technology ($ million)
11 Market Segmentation by Route of Administration
11.1 Market segments
- Chart on Route of Administration - Market share 2025-2030 (%)
- Data Table on Route of Administration - Market share 2025-2030 (%)
- Chart on Comparison by Route of Administration
- Data Table on Comparison by Route of Administration
- Chart on Intramuscular - Market size and forecast 2025-2030 ($ million)
- Data Table on Intramuscular - Market size and forecast 2025-2030 ($ million)
- Chart on Intramuscular - Year-over-year growth 2025-2030 (%)
- Data Table on Intramuscular - Year-over-year growth 2025-2030 (%)
- Chart on Subcutaneous - Market size and forecast 2025-2030 ($ million)
- Data Table on Subcutaneous - Market size and forecast 2025-2030 ($ million)
- Chart on Subcutaneous - Year-over-year growth 2025-2030 (%)
- Data Table on Subcutaneous - Year-over-year growth 2025-2030 (%)
- Chart on Oral - Market size and forecast 2025-2030 ($ million)
- Data Table on Oral - Market size and forecast 2025-2030 ($ million)
- Chart on Oral - Year-over-year growth 2025-2030 (%)
- Data Table on Oral - Year-over-year growth 2025-2030 (%)
- Chart on Intranasal - Market size and forecast 2025-2030 ($ million)
- Data Table on Intranasal - Market size and forecast 2025-2030 ($ million)
- Chart on Intranasal - Year-over-year growth 2025-2030 (%)
- Data Table on Intranasal - Year-over-year growth 2025-2030 (%)
- Chart on Others - Market size and forecast 2025-2030 ($ million)
- Data Table on Others - Market size and forecast 2025-2030 ($ million)
- Chart on Others - Year-over-year growth 2025-2030 (%)
- Data Table on Others - Year-over-year growth 2025-2030 (%)
- Market opportunity by Route of Administration ($ million)
- Data Table on Market opportunity by Route of Administration ($ million)
12 Market Segmentation by Disease Type
12.1 Market segments
- Chart on Disease Type - Market share 2025-2030 (%)
- Data Table on Disease Type - Market share 2025-2030 (%)
- Chart on Comparison by Disease Type
- Data Table on Comparison by Disease Type
- Chart on Influenza - Market size and forecast 2025-2030 ($ million)
- Data Table on Influenza - Market size and forecast 2025-2030 ($ million)
- Chart on Influenza - Year-over-year growth 2025-2030 (%)
- Data Table on Influenza - Year-over-year growth 2025-2030 (%)
- Chart on Human papillomavirus - Market size and forecast 2025-2030 ($ million)
- Data Table on Human papillomavirus - Market size and forecast 2025-2030 ($ million)
- Chart on Human papillomavirus - Year-over-year growth 2025-2030 (%)
- Data Table on Human papillomavirus - Year-over-year growth 2025-2030 (%)
- Chart on Hepatitis - Market size and forecast 2025-2030 ($ million)
- Data Table on Hepatitis - Market size and forecast 2025-2030 ($ million)
- Chart on Hepatitis - Year-over-year growth 2025-2030 (%)
- Data Table on Hepatitis - Year-over-year growth 2025-2030 (%)
- Chart on Measles - Market size and forecast 2025-2030 ($ million)
- Data Table on Measles - Market size and forecast 2025-2030 ($ million)
- Chart on Measles - Year-over-year growth 2025-2030 (%)
- Data Table on Measles - Year-over-year growth 2025-2030 (%)
- Chart on Others - Market size and forecast 2025-2030 ($ million)
- Data Table on Others - Market size and forecast 2025-2030 ($ million)
- Chart on Others - Year-over-year growth 2025-2030 (%)
- Data Table on Others - Year-over-year growth 2025-2030 (%)
- Market opportunity by Disease Type ($ million)
- Data Table on Market opportunity by Disease Type ($ million)
13 Market Segmentation by Age Group
13.1 Market segments
- Chart on Age Group - Market share 2025-2030 (%)
- Data Table on Age Group - Market share 2025-2030 (%)
- Chart on Comparison by Age Group
- Data Table on Comparison by Age Group
- Chart on Pediatric - Market size and forecast 2025-2030 ($ million)
- Data Table on Pediatric - Market size and forecast 2025-2030 ($ million)
- Chart on Pediatric - Year-over-year growth 2025-2030 (%)
- Data Table on Pediatric - Year-over-year growth 2025-2030 (%)
- Chart on Adult - Market size and forecast 2025-2030 ($ million)
- Data Table on Adult - Market size and forecast 2025-2030 ($ million)
- Chart on Adult - Year-over-year growth 2025-2030 (%)
- Data Table on Adult - Year-over-year growth 2025-2030 (%)
- Chart on Adolescent - Market size and forecast 2025-2030 ($ million)
- Data Table on Adolescent - Market size and forecast 2025-2030 ($ million)
- Chart on Adolescent - Year-over-year growth 2025-2030 (%)
- Data Table on Adolescent - Year-over-year growth 2025-2030 (%)
- Chart on Geriatric - Market size and forecast 2025-2030 ($ million)
- Data Table on Geriatric - Market size and forecast 2025-2030 ($ million)
- Chart on Geriatric - Year-over-year growth 2025-2030 (%)
- Data Table on Geriatric - Year-over-year growth 2025-2030 (%)
- Market opportunity by Age Group ($ million)
- Data Table on Market opportunity by Age Group ($ million)
14 Customer Landscape
14.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
15 Geographic Landscape
15.1 Geographic segmentation
- Chart on Market share by geography 2025-2030 (%)
- Data Table on Market share by geography 2025-2030 (%)
- Chart on Geographic comparison
- Data Table on Geographic comparison
- Chart on North America - Market size and forecast 2025-2030 ($ million)
- Data Table on North America - Market size and forecast 2025-2030 ($ million)
- Chart on North America - Year-over-year growth 2025-2030 (%)
- Data Table on North America - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - North America
- Data Table on Regional Comparison - North America
- Chart on US - Market size and forecast 2025-2030 ($ million)
- Data Table on US - Market size and forecast 2025-2030 ($ million)
- Chart on US - Year-over-year growth 2025-2030 (%)
- Data Table on US - Year-over-year growth 2025-2030 (%)
- Chart on Canada - Market size and forecast 2025-2030 ($ million)
- Data Table on Canada - Market size and forecast 2025-2030 ($ million)
- Chart on Canada - Year-over-year growth 2025-2030 (%)
- Data Table on Canada - Year-over-year growth 2025-2030 (%)
- Chart on Mexico - Market size and forecast 2025-2030 ($ million)
- Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
- Chart on Mexico - Year-over-year growth 2025-2030 (%)
- Data Table on Mexico - Year-over-year growth 2025-2030 (%)
- Chart on Europe - Market size and forecast 2025-2030 ($ million)
- Data Table on Europe - Market size and forecast 2025-2030 ($ million)
- Chart on Europe - Year-over-year growth 2025-2030 (%)
- Data Table on Europe - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Europe
- Data Table on Regional Comparison - Europe
- Chart on Germany - Market size and forecast 2025-2030 ($ million)
- Data Table on Germany - Market size and forecast 2025-2030 ($ million)
- Chart on Germany - Year-over-year growth 2025-2030 (%)
- Data Table on Germany - Year-over-year growth 2025-2030 (%)
- Chart on France - Market size and forecast 2025-2030 ($ million)
- Data Table on France - Market size and forecast 2025-2030 ($ million)
- Chart on France - Year-over-year growth 2025-2030 (%)
- Data Table on France - Year-over-year growth 2025-2030 (%)
- Chart on UK - Market size and forecast 2025-2030 ($ million)
- Data Table on UK - Market size and forecast 2025-2030 ($ million)
- Chart on UK - Year-over-year growth 2025-2030 (%)
- Data Table on UK - Year-over-year growth 2025-2030 (%)
- Chart on Italy - Market size and forecast 2025-2030 ($ million)
- Data Table on Italy - Market size and forecast 2025-2030 ($ million)
- Chart on Italy - Year-over-year growth 2025-2030 (%)
- Data Table on Italy - Year-over-year growth 2025-2030 (%)
- Chart on Russia - Market size and forecast 2025-2030 ($ million)
- Data Table on Russia - Market size and forecast 2025-2030 ($ million)
- Chart on Russia - Year-over-year growth 2025-2030 (%)
- Data Table on Russia - Year-over-year growth 2025-2030 (%)
- Chart on Spain - Market size and forecast 2025-2030 ($ million)
- Data Table on Spain - Market size and forecast 2025-2030 ($ million)
- Chart on Spain - Year-over-year growth 2025-2030 (%)
- Data Table on Spain - Year-over-year growth 2025-2030 (%)
- Chart on Asia - Market size and forecast 2025-2030 ($ million)
- Data Table on Asia - Market size and forecast 2025-2030 ($ million)
- Chart on Asia - Year-over-year growth 2025-2030 (%)
- Data Table on Asia - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Asia
- Data Table on Regional Comparison - Asia
- Chart on China - Market size and forecast 2025-2030 ($ million)
- Data Table on China - Market size and forecast 2025-2030 ($ million)
- Chart on China - Year-over-year growth 2025-2030 (%)
- Data Table on China - Year-over-year growth 2025-2030 (%)
- Chart on India - Market size and forecast 2025-2030 ($ million)
- Data Table on India - Market size and forecast 2025-2030 ($ million)
- Chart on India - Year-over-year growth 2025-2030 (%)
- Data Table on India - Year-over-year growth 2025-2030 (%)
- Chart on Japan - Market size and forecast 2025-2030 ($ million)
- Data Table on Japan - Market size and forecast 2025-2030 ($ million)
- Chart on Japan - Year-over-year growth 2025-2030 (%)
- Data Table on Japan - Year-over-year growth 2025-2030 (%)
- Chart on South Korea - Market size and forecast 2025-2030 ($ million)
- Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
- Chart on South Korea - Year-over-year growth 2025-2030 (%)
- Data Table on South Korea - Year-over-year growth 2025-2030 (%)
- Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
- Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
- Chart on Indonesia - Year-over-year growth 2025-2030 (%)
- Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
- Chart on Thailand - Market size and forecast 2025-2030 ($ million)
- Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
- Chart on Thailand - Year-over-year growth 2025-2030 (%)
- Data Table on Thailand - Year-over-year growth 2025-2030 (%)
- Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Rest of World (ROW)
- Data Table on Regional Comparison - Rest of World (ROW)
- Chart on Brazil - Market size and forecast 2025-2030 ($ million)
- Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
- Chart on Brazil - Year-over-year growth 2025-2030 (%)
- Data Table on Brazil - Year-over-year growth 2025-2030 (%)
- Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
- Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
- Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
- Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
- Chart on South Africa - Market size and forecast 2025-2030 ($ million)
- Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
- Chart on South Africa - Year-over-year growth 2025-2030 (%)
- Data Table on South Africa - Year-over-year growth 2025-2030 (%)
- Chart on Egypt - Market size and forecast 2025-2030 ($ million)
- Data Table on Egypt - Market size and forecast 2025-2030 ($ million)
- Chart on Egypt - Year-over-year growth 2025-2030 (%)
- Data Table on Egypt - Year-over-year growth 2025-2030 (%)
- Chart on UAE - Market size and forecast 2025-2030 ($ million)
- Data Table on UAE - Market size and forecast 2025-2030 ($ million)
- Chart on UAE - Year-over-year growth 2025-2030 (%)
- Data Table on UAE - Year-over-year growth 2025-2030 (%)
- Chart on Argentina - Market size and forecast 2025-2030 ($ million)
- Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
- Chart on Argentina - Year-over-year growth 2025-2030 (%)
- Data Table on Argentina - Year-over-year growth 2025-2030 (%)
- Chart on Colombia - Market size and forecast 2025-2030 ($ million)
- Data Table on Colombia - Market size and forecast 2025-2030 ($ million)
- Chart on Colombia - Year-over-year growth 2025-2030 (%)
- Data Table on Colombia - Year-over-year growth 2025-2030 (%)
- Chart on Nigeria - Market size and forecast 2025-2030 ($ million)
- Data Table on Nigeria - Market size and forecast 2025-2030 ($ million)
- Chart on Nigeria - Year-over-year growth 2025-2030 (%)
- Data Table on Nigeria - Year-over-year growth 2025-2030 (%)
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
16 Drivers, Challenges, and Opportunity
16.1 Market drivers
- Expansion of public health initiatives and national immunization programs
- Technological advancements in vaccine platforms and manufacturing scalability
- Rising global emphasis on preventive healthcare and pandemic preparedness
- Stringent and fragmented regulatory frameworks across divergent jurisdictions
- Vulnerabilities and cold-chain bottlenecks in global distribution infrastructure
- Pervasive vaccine hesitancy amplified by digital misinformation campaigns
- Impact of drivers and challenges in 2025 and 2030
- Accelerated adoption of AI in vaccine design and antigen selection
- Proliferation of multivalent and combination formulations to overcome immunization fatigue
- Localization of manufacturing infrastructure and regional supply chain decentralization
17 Competitive Landscape
17.1 Overview
17.2 Competitive Landscape
17.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- Overview on factors of disruption
- Impact of key risks on business
18 Competitive Analysis
18.1 Companies profiled
- Companies covered
- Company ranking index
- Matrix on companies position and classification
- AstraZeneca Plc - Overview
- AstraZeneca Plc - Business segments
- AstraZeneca Plc - Key news
- AstraZeneca Plc - Key offerings
- AstraZeneca Plc - Segment focus
- SWOT
- BioKangtai - Overview
- BioKangtai - Product / Service
- BioKangtai - Key offerings
- SWOT
- BioNTech SE - Overview
- BioNTech SE - Product / Service
- BioNTech SE - Key offerings
- SWOT
- CSL Seqirus - Overview
- CSL Seqirus - Product / Service
- CSL Seqirus - Key offerings
- SWOT
- Emergent BioSolutions Inc. - Overview
- Emergent BioSolutions Inc. - Product / Service
- Emergent BioSolutions Inc. - Key offerings
- SWOT
- GlaxoSmithKline Plc - Overview
- GlaxoSmithKline Plc - Business segments
- GlaxoSmithKline Plc - Key news
- GlaxoSmithKline Plc - Key offerings
- GlaxoSmithKline Plc - Segment focus
- SWOT
- Inovio Pharmaceuticals Inc. - Overview
- Inovio Pharmaceuticals Inc. - Product / Service
- Inovio Pharmaceuticals Inc. - Key offerings
- SWOT
- Johnson and Johnson - Overview
- Johnson and Johnson - Business segments
- Johnson and Johnson - Key news
- Johnson and Johnson - Key offerings
- Johnson and Johnson - Segment focus
- SWOT
- Merck and Co. Inc. - Overview
- Merck and Co. Inc. - Business segments
- Merck and Co. Inc. - Key news
- Merck and Co. Inc. - Key offerings
- Merck and Co. Inc. - Segment focus
- SWOT
- Mitsubishi Tanabe Pharma Corp. - Overview
- Mitsubishi Tanabe Pharma Corp. - Product / Service
- Mitsubishi Tanabe Pharma Corp. - Key offerings
- SWOT
- Moderna Inc. - Overview
- Moderna Inc. - Product / Service
- Moderna Inc. - Key offerings
- SWOT
- Pfizer Inc. - Overview
- Pfizer Inc. - Business segments
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
- Pfizer Inc. - Segment focus
- SWOT
- Sanofi SA - Overview
- Sanofi SA - Business segments
- Sanofi SA - Key news
- Sanofi SA - Key offerings
- Sanofi SA - Segment focus
- SWOT
- Sinopharm - Overview
- Sinopharm - Product / Service
- Sinopharm - Key offerings
- SWOT
- Takeda Pharmaceutical Ltd. - Overview
- Takeda Pharmaceutical Ltd. - Business segments
- Takeda Pharmaceutical Ltd. - Key news
- Takeda Pharmaceutical Ltd. - Key offerings
- Takeda Pharmaceutical Ltd. - Segment focus
- SWOT
19 Appendix
19.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- Inclusions checklist
- Exclusions checklist
- Currency conversion rates for US$
- Research methodology
- Information sources
- Data validation
- Validation techniques employed for market sizing
- Data synthesis
- 360 degree market analysis
- List of abbreviations
List of Exhibits
Exhibit 1: Executive Summary - Chart on Market Overview
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Type
Exhibit 6: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 7: Executive Summary - Chart on Market Segmentation by Technology
Exhibit 8: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 9: Executive Summary - Chart on Market Segmentation by Disease Type
Exhibit 10: Executive Summary - Chart on Market Segmentation by Age Group
Exhibit 11: Executive Summary - Chart on Incremental Growth
Exhibit 12: Executive Summary - Data Table on Incremental Growth
Exhibit 13: Executive Summary - Chart on Company Market Positioning
Exhibit 14: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 15: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 16: Chart on Overview on factors of disruption
Exhibit 17: Chart on Impact of drivers and challenges in 2025 and 2030
Exhibit 18: Chart on Parent Market
Exhibit 19: Data Table on - Parent Market
Exhibit 20: Chart on Market characteristics analysis
Exhibit 21: Chart on Value chain analysis
Exhibit 22: Data Table on Offerings of companies included in the market definition
Exhibit 23: Market segments
Exhibit 24: Chart on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 25: Data Table on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 26: Chart on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 27: Data Table on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 28: Historic Market Size - Data Table on Global Vaccines Market 2020 - 2024 ($ million)
Exhibit 29: Historic Market Size - Type Segment 2020 - 2024 ($ million)
Exhibit 30: Historic Market Size - End-user Segment 2020 - 2024 ($ million)
Exhibit 31: Historic Market Size - Technology Segment 2020 - 2024 ($ million)
Exhibit 32: Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million)
Exhibit 33: Historic Market Size - Disease Type Segment 2020 - 2024 ($ million)
Exhibit 34: Historic Market Size - Age Group Segment 2020 - 2024 ($ million)
Exhibit 35: Historic Market Size - Geography Segment 2020 - 2024 ($ million)
Exhibit 36: Historic Market Size - Country Segment 2020 - 2024 ($ million)
Exhibit 37: Five forces analysis - Comparison between 2025 and 2030
Exhibit 38: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibit 39: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibit 40: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibit 41: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibit 42: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibit 43: Chart on Market condition - Five forces 2025 and 2030
Exhibit 44: Chart on Type - Market share 2025-2030 (%)
Exhibit 45: Data Table on Type - Market share 2025-2030 (%)
Exhibit 46: Chart on Comparison by Type
Exhibit 47: Data Table on Comparison by Type
Exhibit 48: Chart on Subunit vaccines - Market size and forecast 2025-2030 ($ million)
Exhibit 49: Data Table on Subunit vaccines - Market size and forecast 2025-2030 ($ million)
Exhibit 50: Chart on Subunit vaccines - Year-over-year growth 2025-2030 (%)
Exhibit 51: Data Table on Subunit vaccines - Year-over-year growth 2025-2030 (%)
Exhibit 52: Chart on Live attenuated vaccines - Market size and forecast 2025-2030 ($ million)
Exhibit 53: Data Table on Live attenuated vaccines - Market size and forecast 2025-2030 ($ million)
Exhibit 54: Chart on Live attenuated vaccines - Year-over-year growth 2025-2030 (%)
Exhibit 55: Data Table on Live attenuated vaccines - Year-over-year growth 2025-2030 (%)
Exhibit 56: Chart on Inactivated vaccines - Market size and forecast 2025-2030 ($ million)
Exhibit 57: Data Table on Inactivated vaccines - Market size and forecast 2025-2030 ($ million)
Exhibit 58: Chart on Inactivated vaccines - Year-over-year growth 2025-2030 (%)
Exhibit 59: Data Table on Inactivated vaccines - Year-over-year growth 2025-2030 (%)
Exhibit 60: Chart on Toxoid vaccines - Market size and forecast 2025-2030 ($ million)
Exhibit 61: Data Table on Toxoid vaccines - Market size and forecast 2025-2030 ($ million)
Exhibit 62: Chart on Toxoid vaccines - Year-over-year growth 2025-2030 (%)
Exhibit 63: Data Table on Toxoid vaccines - Year-over-year growth 2025-2030 (%)
Exhibit 64: Chart on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 65: Data Table on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 66: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 67: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 68: Market opportunity by Type ($ million)
Exhibit 69: Data Table on Market opportunity by Type ($ million)
Exhibit 70: Chart on End-user - Market share 2025-2030 (%)
Exhibit 71: Data Table on End-user - Market share 2025-2030 (%)
Exhibit 72: Chart on Comparison by End-user
Exhibit 73: Data Table on Comparison by End-user
Exhibit 74: Chart on Hospitals - Market size and forecast 2025-2030 ($ million)
Exhibit 75: Data Table on Hospitals - Market size and forecast 2025-2030 ($ million)
Exhibit 76: Chart on Hospitals - Year-over-year growth 2025-2030 (%)
Exhibit 77: Data Table on Hospitals - Year-over-year growth 2025-2030 (%)
Exhibit 78: Chart on Clinics - Market size and forecast 2025-2030 ($ million)
Exhibit 79: Data Table on Clinics - Market size and forecast 2025-2030 ($ million)
Exhibit 80: Chart on Clinics - Year-over-year growth 2025-2030 (%)
Exhibit 81: Data Table on Clinics - Year-over-year growth 2025-2030 (%)
Exhibit 82: Market opportunity by End-user ($ million)
Exhibit 83: Data Table on Market opportunity by End-user ($ million)
Exhibit 84: Chart on Technology - Market share 2025-2030 (%)
Exhibit 85: Data Table on Technology - Market share 2025-2030 (%)
Exhibit 86: Chart on Comparison by Technology
Exhibit 87: Data Table on Comparison by Technology
Exhibit 88: Chart on mRNA vaccines - Market size and forecast 2025-2030 ($ million)
Exhibit 89: Data Table on mRNA vaccines - Market size and forecast 2025-2030 ($ million)
Exhibit 90: Chart on mRNA vaccines - Year-over-year growth 2025-2030 (%)
Exhibit 91: Data Table on mRNA vaccines - Year-over-year growth 2025-2030 (%)
Exhibit 92: Chart on Viral vector vaccines - Market size and forecast 2025-2030 ($ million)
Exhibit 93: Data Table on Viral vector vaccines - Market size and forecast 2025-2030 ($ million)
Exhibit 94: Chart on Viral vector vaccines - Year-over-year growth 2025-2030 (%)
Exhibit 95: Data Table on Viral vector vaccines - Year-over-year growth 2025-2030 (%)
Exhibit 96: Chart on Protein based vaccines - Market size and forecast 2025-2030 ($ million)
Exhibit 97: Data Table on Protein based vaccines - Market size and forecast 2025-2030 ($ million)
Exhibit 98: Chart on Protein based vaccines - Year-over-year growth 2025-2030 (%)
Exhibit 99: Data Table on Protein based vaccines - Year-over-year growth 2025-2030 (%)
Exhibit 100: Chart on DNA vaccines - Market size and forecast 2025-2030 ($ million)
Exhibit 101: Data Table on DNA vaccines - Market size and forecast 2025-2030 ($ million)
Exhibit 102: Chart on DNA vaccines - Year-over-year growth 2025-2030 (%)
Exhibit 103: Data Table on DNA vaccines - Year-over-year growth 2025-2030 (%)
Exhibit 104: Chart on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 105: Data Table on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 106: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 107: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 108: Market opportunity by Technology ($ million)
Exhibit 109: Data Table on Market opportunity by Technology ($ million)
Exhibit 110: Chart on Route of Administration - Market share 2025-2030 (%)
Exhibit 111: Data Table on Route of Administration - Market share 2025-2030 (%)
Exhibit 112: Chart on Comparison by Route of Administration
Exhibit 113: Data Table on Comparison by Route of Administration
Exhibit 114: Chart on Intramuscular - Market size and forecast 2025-2030 ($ million)
Exhibit 115: Data Table on Intramuscular - Market size and forecast 2025-2030 ($ million)
Exhibit 116: Chart on Intramuscular - Year-over-year growth 2025-2030 (%)
Exhibit 117: Data Table on Intramuscular - Year-over-year growth 2025-2030 (%)
Exhibit 118: Chart on Subcutaneous - Market size and forecast 2025-2030 ($ million)
Exhibit 119: Data Table on Subcutaneous - Market size and forecast 2025-2030 ($ million)
Exhibit 120: Chart on Subcutaneous - Year-over-year growth 2025-2030 (%)
Exhibit 121: Data Table on Subcutaneous - Year-over-year growth 2025-2030 (%)
Exhibit 122: Chart on Oral - Market size and forecast 2025-2030 ($ million)
Exhibit 123: Data Table on Oral - Market size and forecast 2025-2030 ($ million)
Exhibit 124: Chart on Oral - Year-over-year growth 2025-2030 (%)
Exhibit 125: Data Table on Oral - Year-over-year growth 2025-2030 (%)
Exhibit 126: Chart on Intranasal - Market size and forecast 2025-2030 ($ million)
Exhibit 127: Data Table on Intranasal - Market size and forecast 2025-2030 ($ million)
Exhibit 128: Chart on Intranasal - Year-over-year growth 2025-2030 (%)
Exhibit 129: Data Table on Intranasal - Year-over-year growth 2025-2030 (%)
Exhibit 130: Chart on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 131: Data Table on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 132: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 133: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 134: Market opportunity by Route of Administration ($ million)
Exhibit 135: Data Table on Market opportunity by Route of Administration ($ million)
Exhibit 136: Chart on Disease Type - Market share 2025-2030 (%)
Exhibit 137: Data Table on Disease Type - Market share 2025-2030 (%)
Exhibit 138: Chart on Comparison by Disease Type
Exhibit 139: Data Table on Comparison by Disease Type
Exhibit 140: Chart on Influenza - Market size and forecast 2025-2030 ($ million)
Exhibit 141: Data Table on Influenza - Market size and forecast 2025-2030 ($ million)
Exhibit 142: Chart on Influenza - Year-over-year growth 2025-2030 (%)
Exhibit 143: Data Table on Influenza - Year-over-year growth 2025-2030 (%)
Exhibit 144: Chart on Human papillomavirus - Market size and forecast 2025-2030 ($ million)
Exhibit 145: Data Table on Human papillomavirus - Market size and forecast 2025-2030 ($ million)
Exhibit 146: Chart on Human papillomavirus - Year-over-year growth 2025-2030 (%)
Exhibit 147: Data Table on Human papillomavirus - Year-over-year growth 2025-2030 (%)
Exhibit 148: Chart on Hepatitis - Market size and forecast 2025-2030 ($ million)
Exhibit 149: Data Table on Hepatitis - Market size and forecast 2025-2030 ($ million)
Exhibit 150: Chart on Hepatitis - Year-over-year growth 2025-2030 (%)
Exhibit 151: Data Table on Hepatitis - Year-over-year growth 2025-2030 (%)
Exhibit 152: Chart on Measles - Market size and forecast 2025-2030 ($ million)
Exhibit 153: Data Table on Measles - Market size and forecast 2025-2030 ($ million)
Exhibit 154: Chart on Measles - Year-over-year growth 2025-2030 (%)
Exhibit 155: Data Table on Measles - Year-over-year growth 2025-2030 (%)
Exhibit 156: Chart on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 157: Data Table on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 158: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 159: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 160: Market opportunity by Disease Type ($ million)
Exhibit 161: Data Table on Market opportunity by Disease Type ($ million)
Exhibit 162: Chart on Age Group - Market share 2025-2030 (%)
Exhibit 163: Data Table on Age Group - Market share 2025-2030 (%)
Exhibit 164: Chart on Comparison by Age Group
Exhibit 165: Data Table on Comparison by Age Group
Exhibit 166: Chart on Pediatric - Market size and forecast 2025-2030 ($ million)
Exhibit 167: Data Table on Pediatric - Market size and forecast 2025-2030 ($ million)
Exhibit 168: Chart on Pediatric - Year-over-year growth 2025-2030 (%)
Exhibit 169: Data Table on Pediatric - Year-over-year growth 2025-2030 (%)
Exhibit 170: Chart on Adult - Market size and forecast 2025-2030 ($ million)
Exhibit 171: Data Table on Adult - Market size and forecast 2025-2030 ($ million)
Exhibit 172: Chart on Adult - Year-over-year growth 2025-2030 (%)
Exhibit 173: Data Table on Adult - Year-over-year growth 2025-2030 (%)
Exhibit 174: Chart on Adolescent - Market size and forecast 2025-2030 ($ million)
Exhibit 175: Data Table on Adolescent - Market size and forecast 2025-2030 ($ million)
Exhibit 176: Chart on Adolescent - Year-over-year growth 2025-2030 (%)
Exhibit 177: Data Table on Adolescent - Year-over-year growth 2025-2030 (%)
Exhibit 178: Chart on Geriatric - Market size and forecast 2025-2030 ($ million)
Exhibit 179: Data Table on Geriatric - Market size and forecast 2025-2030 ($ million)
Exhibit 180: Chart on Geriatric - Year-over-year growth 2025-2030 (%)
Exhibit 181: Data Table on Geriatric - Year-over-year growth 2025-2030 (%)
Exhibit 182: Market opportunity by Age Group ($ million)
Exhibit 183: Data Table on Market opportunity by Age Group ($ million)
Exhibit 184: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 185: Chart on Market share by geography 2025-2030 (%)
Exhibit 186: Data Table on Market share by geography 2025-2030 (%)
Exhibit 187: Chart on Geographic comparison
Exhibit 188: Data Table on Geographic comparison
Exhibit 189: Chart on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 190: Data Table on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 191: Chart on North America - Year-over-year growth 2025-2030 (%)
Exhibit 192: Data Table on North America - Year-over-year growth 2025-2030 (%)
Exhibit 193: Chart on Regional Comparison - North America
Exhibit 194: Data Table on Regional Comparison - North America
Exhibit 195: Chart on US - Market size and forecast 2025-2030 ($ million)
Exhibit 196: Data Table on US - Market size and forecast 2025-2030 ($ million)
Exhibit 197: Chart on US - Year-over-year growth 2025-2030 (%)
Exhibit 198: Data Table on US - Year-over-year growth 2025-2030 (%)
Exhibit 199: Chart on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 200: Data Table on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 201: Chart on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 202: Data Table on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 203: Chart on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 204: Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 205: Chart on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 206: Data Table on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 207: Chart on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 208: Data Table on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 209: Chart on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 210: Data Table on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 211: Chart on Regional Comparison - Europe
Exhibit 212: Data Table on Regional Comparison - Europe
Exhibit 213: Chart on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 214: Data Table on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 215: Chart on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 216: Data Table on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 217: Chart on France - Market size and forecast 2025-2030 ($ million)
Exhibit 218: Data Table on France - Market size and forecast 2025-2030 ($ million)
Exhibit 219: Chart on France - Year-over-year growth 2025-2030 (%)
Exhibit 220: Data Table on France - Year-over-year growth 2025-2030 (%)
Exhibit 221: Chart on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 222: Data Table on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 223: Chart on UK - Year-over-year growth 2025-2030 (%)
Exhibit 224: Data Table on UK - Year-over-year growth 2025-2030 (%)
Exhibit 225: Chart on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 226: Data Table on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 227: Chart on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 228: Data Table on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 229: Chart on Russia - Market size and forecast 2025-2030 ($ million)
Exhibit 230: Data Table on Russia - Market size and forecast 2025-2030 ($ million)
Exhibit 231: Chart on Russia - Year-over-year growth 2025-2030 (%)
Exhibit 232: Data Table on Russia - Year-over-year growth 2025-2030 (%)
Exhibit 233: Chart on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 234: Data Table on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 235: Chart on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 236: Data Table on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 237: Chart on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 238: Data Table on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 239: Chart on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 240: Data Table on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 241: Chart on Regional Comparison - Asia
Exhibit 242: Data Table on Regional Comparison - Asia
Exhibit 243: Chart on China - Market size and forecast 2025-2030 ($ million)
Exhibit 244: Data Table on China - Market size and forecast 2025-2030 ($ million)
Exhibit 245: Chart on China - Year-over-year growth 2025-2030 (%)
Exhibit 246: Data Table on China - Year-over-year growth 2025-2030 (%)
Exhibit 247: Chart on India - Market size and forecast 2025-2030 ($ million)
Exhibit 248: Data Table on India - Market size and forecast 2025-2030 ($ million)
Exhibit 249: Chart on India - Year-over-year growth 2025-2030 (%)
Exhibit 250: Data Table on India - Year-over-year growth 2025-2030 (%)
Exhibit 251: Chart on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 252: Data Table on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 253: Chart on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 254: Data Table on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 255: Chart on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 256: Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 257: Chart on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 258: Data Table on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 259: Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 260: Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 261: Chart on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 262: Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 263: Chart on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 264: Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 265: Chart on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 266: Data Table on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 267: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 268: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 269: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 270: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 271: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 272: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 273: Chart on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 274: Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 275: Chart on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 276: Data Table on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 277: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 278: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 279: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 280: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 281: Chart on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 282: Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 283: Chart on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 284: Data Table on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 285: Chart on Egypt - Market size and forecast 2025-2030 ($ million)
Exhibit 286: Data Table on Egypt - Market size and forecast 2025-2030 ($ million)
Exhibit 287: Chart on Egypt - Year-over-year growth 2025-2030 (%)
Exhibit 288: Data Table on Egypt - Year-over-year growth 2025-2030 (%)
Exhibit 289: Chart on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 290: Data Table on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 291: Chart on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 292: Data Table on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 293: Chart on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 294: Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 295: Chart on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 296: Data Table on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 297: Chart on Colombia - Market size and forecast 2025-2030 ($ million)
Exhibit 298: Data Table on Colombia - Market size and forecast 2025-2030 ($ million)
Exhibit 299: Chart on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 300: Data Table on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 301: Chart on Nigeria - Market size and forecast 2025-2030 ($ million)
Exhibit 302: Data Table on Nigeria - Market size and forecast 2025-2030 ($ million)
Exhibit 303: Chart on Nigeria - Year-over-year growth 2025-2030 (%)
Exhibit 304: Data Table on Nigeria - Year-over-year growth 2025-2030 (%)
Exhibit 305: Market opportunity by geography ($ million)
Exhibit 306: Data Tables on Market opportunity by geography ($ million)
Exhibit 307: Impact of drivers and challenges in 2025 and 2030
Exhibit 308: Overview on criticality of inputs and factors of differentiation
Exhibit 309: Overview on factors of disruption
Exhibit 310: Impact of key risks on business
Exhibit 311: Companies covered
Exhibit 312: Company ranking index
Exhibit 313: Matrix on companies position and classification
Exhibit 314: AstraZeneca Plc - Overview
Exhibit 315: AstraZeneca Plc - Business segments
Exhibit 316: AstraZeneca Plc - Key news
Exhibit 317: AstraZeneca Plc - Key offerings
Exhibit 318: AstraZeneca Plc - Segment focus
Exhibit 319: SWOT
Exhibit 320: BioKangtai - Overview
Exhibit 321: BioKangtai - Product / Service
Exhibit 322: BioKangtai - Key offerings
Exhibit 323: SWOT
Exhibit 324: BioNTech SE - Overview
Exhibit 325: BioNTech SE - Product / Service
Exhibit 326: BioNTech SE - Key offerings
Exhibit 327: SWOT
Exhibit 328: CSL Seqirus - Overview
Exhibit 329: CSL Seqirus - Product / Service
Exhibit 330: CSL Seqirus - Key offerings
Exhibit 331: SWOT
Exhibit 332: Emergent BioSolutions Inc. - Overview
Exhibit 333: Emergent BioSolutions Inc. - Product / Service
Exhibit 334: Emergent BioSolutions Inc. - Key offerings
Exhibit 335: SWOT
Exhibit 336: GlaxoSmithKline Plc - Overview
Exhibit 337: GlaxoSmithKline Plc - Business segments
Exhibit 338: GlaxoSmithKline Plc - Key news
Exhibit 339: GlaxoSmithKline Plc - Key offerings
Exhibit 340: GlaxoSmithKline Plc - Segment focus
Exhibit 341: SWOT
Exhibit 342: Inovio Pharmaceuticals Inc. - Overview
Exhibit 343: Inovio Pharmaceuticals Inc. - Product / Service
Exhibit 344: Inovio Pharmaceuticals Inc. - Key offerings
Exhibit 345: SWOT
Exhibit 346: Johnson and Johnson - Overview
Exhibit 347: Johnson and Johnson - Business segments
Exhibit 348: Johnson and Johnson - Key news
Exhibit 349: Johnson and Johnson - Key offerings
Exhibit 350: Johnson and Johnson - Segment focus
Exhibit 351: SWOT
Exhibit 352: Merck and Co. Inc. - Overview
Exhibit 353: Merck and Co. Inc. - Business segments
Exhibit 354: Merck and Co. Inc. - Key news
Exhibit 355: Merck and Co. Inc. - Key offerings
Exhibit 356: Merck and Co. Inc. - Segment focus
Exhibit 357: SWOT
Exhibit 358: Mitsubishi Tanabe Pharma Corp. - Overview
Exhibit 359: Mitsubishi Tanabe Pharma Corp. - Product / Service
Exhibit 360: Mitsubishi Tanabe Pharma Corp. - Key offerings
Exhibit 361: SWOT
Exhibit 362: Moderna Inc. - Overview
Exhibit 363: Moderna Inc. - Product / Service
Exhibit 364: Moderna Inc. - Key offerings
Exhibit 365: SWOT
Exhibit 366: Pfizer Inc. - Overview
Exhibit 367: Pfizer Inc. - Business segments
Exhibit 368: Pfizer Inc. - Key news
Exhibit 369: Pfizer Inc. - Key offerings
Exhibit 370: Pfizer Inc. - Segment focus
Exhibit 371: SWOT
Exhibit 372: Sanofi SA - Overview
Exhibit 373: Sanofi SA - Business segments
Exhibit 374: Sanofi SA - Key news
Exhibit 375: Sanofi SA - Key offerings
Exhibit 376: Sanofi SA - Segment focus
Exhibit 377: SWOT
Exhibit 378: Sinopharm - Overview
Exhibit 379: Sinopharm - Product / Service
Exhibit 380: Sinopharm - Key offerings
Exhibit 381: SWOT
Exhibit 382: Takeda Pharmaceutical Ltd. - Overview
Exhibit 383: Takeda Pharmaceutical Ltd. - Business segments
Exhibit 384: Takeda Pharmaceutical Ltd. - Key news
Exhibit 385: Takeda Pharmaceutical Ltd. - Key offerings
Exhibit 386: Takeda Pharmaceutical Ltd. - Segment focus
Exhibit 387: SWOT
Exhibit 388: Inclusions checklist
Exhibit 389: Exclusions checklist
Exhibit 390: Currency conversion rates for US$
Exhibit 391: Research methodology
Exhibit 392: Information sources
Exhibit 393: Data validation
Exhibit 394: Validation techniques employed for market sizing
Exhibit 395: Data synthesis
Exhibit 396: 360 degree market analysis
Exhibit 397: List of abbreviations
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Type
Exhibit 6: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 7: Executive Summary - Chart on Market Segmentation by Technology
Exhibit 8: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 9: Executive Summary - Chart on Market Segmentation by Disease Type
Exhibit 10: Executive Summary - Chart on Market Segmentation by Age Group
Exhibit 11: Executive Summary - Chart on Incremental Growth
Exhibit 12: Executive Summary - Data Table on Incremental Growth
Exhibit 13: Executive Summary - Chart on Company Market Positioning
Exhibit 14: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 15: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 16: Chart on Overview on factors of disruption
Exhibit 17: Chart on Impact of drivers and challenges in 2025 and 2030
Exhibit 18: Chart on Parent Market
Exhibit 19: Data Table on - Parent Market
Exhibit 20: Chart on Market characteristics analysis
Exhibit 21: Chart on Value chain analysis
Exhibit 22: Data Table on Offerings of companies included in the market definition
Exhibit 23: Market segments
Exhibit 24: Chart on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 25: Data Table on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 26: Chart on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 27: Data Table on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 28: Historic Market Size - Data Table on Global Vaccines Market 2020 - 2024 ($ million)
Exhibit 29: Historic Market Size - Type Segment 2020 - 2024 ($ million)
Exhibit 30: Historic Market Size - End-user Segment 2020 - 2024 ($ million)
Exhibit 31: Historic Market Size - Technology Segment 2020 - 2024 ($ million)
Exhibit 32: Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million)
Exhibit 33: Historic Market Size - Disease Type Segment 2020 - 2024 ($ million)
Exhibit 34: Historic Market Size - Age Group Segment 2020 - 2024 ($ million)
Exhibit 35: Historic Market Size - Geography Segment 2020 - 2024 ($ million)
Exhibit 36: Historic Market Size - Country Segment 2020 - 2024 ($ million)
Exhibit 37: Five forces analysis - Comparison between 2025 and 2030
Exhibit 38: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibit 39: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibit 40: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibit 41: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibit 42: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibit 43: Chart on Market condition - Five forces 2025 and 2030
Exhibit 44: Chart on Type - Market share 2025-2030 (%)
Exhibit 45: Data Table on Type - Market share 2025-2030 (%)
Exhibit 46: Chart on Comparison by Type
Exhibit 47: Data Table on Comparison by Type
Exhibit 48: Chart on Subunit vaccines - Market size and forecast 2025-2030 ($ million)
Exhibit 49: Data Table on Subunit vaccines - Market size and forecast 2025-2030 ($ million)
Exhibit 50: Chart on Subunit vaccines - Year-over-year growth 2025-2030 (%)
Exhibit 51: Data Table on Subunit vaccines - Year-over-year growth 2025-2030 (%)
Exhibit 52: Chart on Live attenuated vaccines - Market size and forecast 2025-2030 ($ million)
Exhibit 53: Data Table on Live attenuated vaccines - Market size and forecast 2025-2030 ($ million)
Exhibit 54: Chart on Live attenuated vaccines - Year-over-year growth 2025-2030 (%)
Exhibit 55: Data Table on Live attenuated vaccines - Year-over-year growth 2025-2030 (%)
Exhibit 56: Chart on Inactivated vaccines - Market size and forecast 2025-2030 ($ million)
Exhibit 57: Data Table on Inactivated vaccines - Market size and forecast 2025-2030 ($ million)
Exhibit 58: Chart on Inactivated vaccines - Year-over-year growth 2025-2030 (%)
Exhibit 59: Data Table on Inactivated vaccines - Year-over-year growth 2025-2030 (%)
Exhibit 60: Chart on Toxoid vaccines - Market size and forecast 2025-2030 ($ million)
Exhibit 61: Data Table on Toxoid vaccines - Market size and forecast 2025-2030 ($ million)
Exhibit 62: Chart on Toxoid vaccines - Year-over-year growth 2025-2030 (%)
Exhibit 63: Data Table on Toxoid vaccines - Year-over-year growth 2025-2030 (%)
Exhibit 64: Chart on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 65: Data Table on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 66: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 67: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 68: Market opportunity by Type ($ million)
Exhibit 69: Data Table on Market opportunity by Type ($ million)
Exhibit 70: Chart on End-user - Market share 2025-2030 (%)
Exhibit 71: Data Table on End-user - Market share 2025-2030 (%)
Exhibit 72: Chart on Comparison by End-user
Exhibit 73: Data Table on Comparison by End-user
Exhibit 74: Chart on Hospitals - Market size and forecast 2025-2030 ($ million)
Exhibit 75: Data Table on Hospitals - Market size and forecast 2025-2030 ($ million)
Exhibit 76: Chart on Hospitals - Year-over-year growth 2025-2030 (%)
Exhibit 77: Data Table on Hospitals - Year-over-year growth 2025-2030 (%)
Exhibit 78: Chart on Clinics - Market size and forecast 2025-2030 ($ million)
Exhibit 79: Data Table on Clinics - Market size and forecast 2025-2030 ($ million)
Exhibit 80: Chart on Clinics - Year-over-year growth 2025-2030 (%)
Exhibit 81: Data Table on Clinics - Year-over-year growth 2025-2030 (%)
Exhibit 82: Market opportunity by End-user ($ million)
Exhibit 83: Data Table on Market opportunity by End-user ($ million)
Exhibit 84: Chart on Technology - Market share 2025-2030 (%)
Exhibit 85: Data Table on Technology - Market share 2025-2030 (%)
Exhibit 86: Chart on Comparison by Technology
Exhibit 87: Data Table on Comparison by Technology
Exhibit 88: Chart on mRNA vaccines - Market size and forecast 2025-2030 ($ million)
Exhibit 89: Data Table on mRNA vaccines - Market size and forecast 2025-2030 ($ million)
Exhibit 90: Chart on mRNA vaccines - Year-over-year growth 2025-2030 (%)
Exhibit 91: Data Table on mRNA vaccines - Year-over-year growth 2025-2030 (%)
Exhibit 92: Chart on Viral vector vaccines - Market size and forecast 2025-2030 ($ million)
Exhibit 93: Data Table on Viral vector vaccines - Market size and forecast 2025-2030 ($ million)
Exhibit 94: Chart on Viral vector vaccines - Year-over-year growth 2025-2030 (%)
Exhibit 95: Data Table on Viral vector vaccines - Year-over-year growth 2025-2030 (%)
Exhibit 96: Chart on Protein based vaccines - Market size and forecast 2025-2030 ($ million)
Exhibit 97: Data Table on Protein based vaccines - Market size and forecast 2025-2030 ($ million)
Exhibit 98: Chart on Protein based vaccines - Year-over-year growth 2025-2030 (%)
Exhibit 99: Data Table on Protein based vaccines - Year-over-year growth 2025-2030 (%)
Exhibit 100: Chart on DNA vaccines - Market size and forecast 2025-2030 ($ million)
Exhibit 101: Data Table on DNA vaccines - Market size and forecast 2025-2030 ($ million)
Exhibit 102: Chart on DNA vaccines - Year-over-year growth 2025-2030 (%)
Exhibit 103: Data Table on DNA vaccines - Year-over-year growth 2025-2030 (%)
Exhibit 104: Chart on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 105: Data Table on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 106: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 107: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 108: Market opportunity by Technology ($ million)
Exhibit 109: Data Table on Market opportunity by Technology ($ million)
Exhibit 110: Chart on Route of Administration - Market share 2025-2030 (%)
Exhibit 111: Data Table on Route of Administration - Market share 2025-2030 (%)
Exhibit 112: Chart on Comparison by Route of Administration
Exhibit 113: Data Table on Comparison by Route of Administration
Exhibit 114: Chart on Intramuscular - Market size and forecast 2025-2030 ($ million)
Exhibit 115: Data Table on Intramuscular - Market size and forecast 2025-2030 ($ million)
Exhibit 116: Chart on Intramuscular - Year-over-year growth 2025-2030 (%)
Exhibit 117: Data Table on Intramuscular - Year-over-year growth 2025-2030 (%)
Exhibit 118: Chart on Subcutaneous - Market size and forecast 2025-2030 ($ million)
Exhibit 119: Data Table on Subcutaneous - Market size and forecast 2025-2030 ($ million)
Exhibit 120: Chart on Subcutaneous - Year-over-year growth 2025-2030 (%)
Exhibit 121: Data Table on Subcutaneous - Year-over-year growth 2025-2030 (%)
Exhibit 122: Chart on Oral - Market size and forecast 2025-2030 ($ million)
Exhibit 123: Data Table on Oral - Market size and forecast 2025-2030 ($ million)
Exhibit 124: Chart on Oral - Year-over-year growth 2025-2030 (%)
Exhibit 125: Data Table on Oral - Year-over-year growth 2025-2030 (%)
Exhibit 126: Chart on Intranasal - Market size and forecast 2025-2030 ($ million)
Exhibit 127: Data Table on Intranasal - Market size and forecast 2025-2030 ($ million)
Exhibit 128: Chart on Intranasal - Year-over-year growth 2025-2030 (%)
Exhibit 129: Data Table on Intranasal - Year-over-year growth 2025-2030 (%)
Exhibit 130: Chart on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 131: Data Table on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 132: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 133: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 134: Market opportunity by Route of Administration ($ million)
Exhibit 135: Data Table on Market opportunity by Route of Administration ($ million)
Exhibit 136: Chart on Disease Type - Market share 2025-2030 (%)
Exhibit 137: Data Table on Disease Type - Market share 2025-2030 (%)
Exhibit 138: Chart on Comparison by Disease Type
Exhibit 139: Data Table on Comparison by Disease Type
Exhibit 140: Chart on Influenza - Market size and forecast 2025-2030 ($ million)
Exhibit 141: Data Table on Influenza - Market size and forecast 2025-2030 ($ million)
Exhibit 142: Chart on Influenza - Year-over-year growth 2025-2030 (%)
Exhibit 143: Data Table on Influenza - Year-over-year growth 2025-2030 (%)
Exhibit 144: Chart on Human papillomavirus - Market size and forecast 2025-2030 ($ million)
Exhibit 145: Data Table on Human papillomavirus - Market size and forecast 2025-2030 ($ million)
Exhibit 146: Chart on Human papillomavirus - Year-over-year growth 2025-2030 (%)
Exhibit 147: Data Table on Human papillomavirus - Year-over-year growth 2025-2030 (%)
Exhibit 148: Chart on Hepatitis - Market size and forecast 2025-2030 ($ million)
Exhibit 149: Data Table on Hepatitis - Market size and forecast 2025-2030 ($ million)
Exhibit 150: Chart on Hepatitis - Year-over-year growth 2025-2030 (%)
Exhibit 151: Data Table on Hepatitis - Year-over-year growth 2025-2030 (%)
Exhibit 152: Chart on Measles - Market size and forecast 2025-2030 ($ million)
Exhibit 153: Data Table on Measles - Market size and forecast 2025-2030 ($ million)
Exhibit 154: Chart on Measles - Year-over-year growth 2025-2030 (%)
Exhibit 155: Data Table on Measles - Year-over-year growth 2025-2030 (%)
Exhibit 156: Chart on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 157: Data Table on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 158: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 159: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 160: Market opportunity by Disease Type ($ million)
Exhibit 161: Data Table on Market opportunity by Disease Type ($ million)
Exhibit 162: Chart on Age Group - Market share 2025-2030 (%)
Exhibit 163: Data Table on Age Group - Market share 2025-2030 (%)
Exhibit 164: Chart on Comparison by Age Group
Exhibit 165: Data Table on Comparison by Age Group
Exhibit 166: Chart on Pediatric - Market size and forecast 2025-2030 ($ million)
Exhibit 167: Data Table on Pediatric - Market size and forecast 2025-2030 ($ million)
Exhibit 168: Chart on Pediatric - Year-over-year growth 2025-2030 (%)
Exhibit 169: Data Table on Pediatric - Year-over-year growth 2025-2030 (%)
Exhibit 170: Chart on Adult - Market size and forecast 2025-2030 ($ million)
Exhibit 171: Data Table on Adult - Market size and forecast 2025-2030 ($ million)
Exhibit 172: Chart on Adult - Year-over-year growth 2025-2030 (%)
Exhibit 173: Data Table on Adult - Year-over-year growth 2025-2030 (%)
Exhibit 174: Chart on Adolescent - Market size and forecast 2025-2030 ($ million)
Exhibit 175: Data Table on Adolescent - Market size and forecast 2025-2030 ($ million)
Exhibit 176: Chart on Adolescent - Year-over-year growth 2025-2030 (%)
Exhibit 177: Data Table on Adolescent - Year-over-year growth 2025-2030 (%)
Exhibit 178: Chart on Geriatric - Market size and forecast 2025-2030 ($ million)
Exhibit 179: Data Table on Geriatric - Market size and forecast 2025-2030 ($ million)
Exhibit 180: Chart on Geriatric - Year-over-year growth 2025-2030 (%)
Exhibit 181: Data Table on Geriatric - Year-over-year growth 2025-2030 (%)
Exhibit 182: Market opportunity by Age Group ($ million)
Exhibit 183: Data Table on Market opportunity by Age Group ($ million)
Exhibit 184: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 185: Chart on Market share by geography 2025-2030 (%)
Exhibit 186: Data Table on Market share by geography 2025-2030 (%)
Exhibit 187: Chart on Geographic comparison
Exhibit 188: Data Table on Geographic comparison
Exhibit 189: Chart on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 190: Data Table on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 191: Chart on North America - Year-over-year growth 2025-2030 (%)
Exhibit 192: Data Table on North America - Year-over-year growth 2025-2030 (%)
Exhibit 193: Chart on Regional Comparison - North America
Exhibit 194: Data Table on Regional Comparison - North America
Exhibit 195: Chart on US - Market size and forecast 2025-2030 ($ million)
Exhibit 196: Data Table on US - Market size and forecast 2025-2030 ($ million)
Exhibit 197: Chart on US - Year-over-year growth 2025-2030 (%)
Exhibit 198: Data Table on US - Year-over-year growth 2025-2030 (%)
Exhibit 199: Chart on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 200: Data Table on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 201: Chart on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 202: Data Table on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 203: Chart on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 204: Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 205: Chart on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 206: Data Table on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 207: Chart on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 208: Data Table on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 209: Chart on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 210: Data Table on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 211: Chart on Regional Comparison - Europe
Exhibit 212: Data Table on Regional Comparison - Europe
Exhibit 213: Chart on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 214: Data Table on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 215: Chart on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 216: Data Table on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 217: Chart on France - Market size and forecast 2025-2030 ($ million)
Exhibit 218: Data Table on France - Market size and forecast 2025-2030 ($ million)
Exhibit 219: Chart on France - Year-over-year growth 2025-2030 (%)
Exhibit 220: Data Table on France - Year-over-year growth 2025-2030 (%)
Exhibit 221: Chart on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 222: Data Table on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 223: Chart on UK - Year-over-year growth 2025-2030 (%)
Exhibit 224: Data Table on UK - Year-over-year growth 2025-2030 (%)
Exhibit 225: Chart on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 226: Data Table on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 227: Chart on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 228: Data Table on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 229: Chart on Russia - Market size and forecast 2025-2030 ($ million)
Exhibit 230: Data Table on Russia - Market size and forecast 2025-2030 ($ million)
Exhibit 231: Chart on Russia - Year-over-year growth 2025-2030 (%)
Exhibit 232: Data Table on Russia - Year-over-year growth 2025-2030 (%)
Exhibit 233: Chart on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 234: Data Table on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 235: Chart on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 236: Data Table on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 237: Chart on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 238: Data Table on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 239: Chart on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 240: Data Table on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 241: Chart on Regional Comparison - Asia
Exhibit 242: Data Table on Regional Comparison - Asia
Exhibit 243: Chart on China - Market size and forecast 2025-2030 ($ million)
Exhibit 244: Data Table on China - Market size and forecast 2025-2030 ($ million)
Exhibit 245: Chart on China - Year-over-year growth 2025-2030 (%)
Exhibit 246: Data Table on China - Year-over-year growth 2025-2030 (%)
Exhibit 247: Chart on India - Market size and forecast 2025-2030 ($ million)
Exhibit 248: Data Table on India - Market size and forecast 2025-2030 ($ million)
Exhibit 249: Chart on India - Year-over-year growth 2025-2030 (%)
Exhibit 250: Data Table on India - Year-over-year growth 2025-2030 (%)
Exhibit 251: Chart on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 252: Data Table on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 253: Chart on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 254: Data Table on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 255: Chart on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 256: Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 257: Chart on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 258: Data Table on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 259: Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 260: Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 261: Chart on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 262: Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 263: Chart on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 264: Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 265: Chart on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 266: Data Table on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 267: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 268: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 269: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 270: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 271: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 272: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 273: Chart on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 274: Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 275: Chart on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 276: Data Table on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 277: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 278: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 279: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 280: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 281: Chart on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 282: Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 283: Chart on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 284: Data Table on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 285: Chart on Egypt - Market size and forecast 2025-2030 ($ million)
Exhibit 286: Data Table on Egypt - Market size and forecast 2025-2030 ($ million)
Exhibit 287: Chart on Egypt - Year-over-year growth 2025-2030 (%)
Exhibit 288: Data Table on Egypt - Year-over-year growth 2025-2030 (%)
Exhibit 289: Chart on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 290: Data Table on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 291: Chart on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 292: Data Table on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 293: Chart on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 294: Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 295: Chart on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 296: Data Table on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 297: Chart on Colombia - Market size and forecast 2025-2030 ($ million)
Exhibit 298: Data Table on Colombia - Market size and forecast 2025-2030 ($ million)
Exhibit 299: Chart on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 300: Data Table on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 301: Chart on Nigeria - Market size and forecast 2025-2030 ($ million)
Exhibit 302: Data Table on Nigeria - Market size and forecast 2025-2030 ($ million)
Exhibit 303: Chart on Nigeria - Year-over-year growth 2025-2030 (%)
Exhibit 304: Data Table on Nigeria - Year-over-year growth 2025-2030 (%)
Exhibit 305: Market opportunity by geography ($ million)
Exhibit 306: Data Tables on Market opportunity by geography ($ million)
Exhibit 307: Impact of drivers and challenges in 2025 and 2030
Exhibit 308: Overview on criticality of inputs and factors of differentiation
Exhibit 309: Overview on factors of disruption
Exhibit 310: Impact of key risks on business
Exhibit 311: Companies covered
Exhibit 312: Company ranking index
Exhibit 313: Matrix on companies position and classification
Exhibit 314: AstraZeneca Plc - Overview
Exhibit 315: AstraZeneca Plc - Business segments
Exhibit 316: AstraZeneca Plc - Key news
Exhibit 317: AstraZeneca Plc - Key offerings
Exhibit 318: AstraZeneca Plc - Segment focus
Exhibit 319: SWOT
Exhibit 320: BioKangtai - Overview
Exhibit 321: BioKangtai - Product / Service
Exhibit 322: BioKangtai - Key offerings
Exhibit 323: SWOT
Exhibit 324: BioNTech SE - Overview
Exhibit 325: BioNTech SE - Product / Service
Exhibit 326: BioNTech SE - Key offerings
Exhibit 327: SWOT
Exhibit 328: CSL Seqirus - Overview
Exhibit 329: CSL Seqirus - Product / Service
Exhibit 330: CSL Seqirus - Key offerings
Exhibit 331: SWOT
Exhibit 332: Emergent BioSolutions Inc. - Overview
Exhibit 333: Emergent BioSolutions Inc. - Product / Service
Exhibit 334: Emergent BioSolutions Inc. - Key offerings
Exhibit 335: SWOT
Exhibit 336: GlaxoSmithKline Plc - Overview
Exhibit 337: GlaxoSmithKline Plc - Business segments
Exhibit 338: GlaxoSmithKline Plc - Key news
Exhibit 339: GlaxoSmithKline Plc - Key offerings
Exhibit 340: GlaxoSmithKline Plc - Segment focus
Exhibit 341: SWOT
Exhibit 342: Inovio Pharmaceuticals Inc. - Overview
Exhibit 343: Inovio Pharmaceuticals Inc. - Product / Service
Exhibit 344: Inovio Pharmaceuticals Inc. - Key offerings
Exhibit 345: SWOT
Exhibit 346: Johnson and Johnson - Overview
Exhibit 347: Johnson and Johnson - Business segments
Exhibit 348: Johnson and Johnson - Key news
Exhibit 349: Johnson and Johnson - Key offerings
Exhibit 350: Johnson and Johnson - Segment focus
Exhibit 351: SWOT
Exhibit 352: Merck and Co. Inc. - Overview
Exhibit 353: Merck and Co. Inc. - Business segments
Exhibit 354: Merck and Co. Inc. - Key news
Exhibit 355: Merck and Co. Inc. - Key offerings
Exhibit 356: Merck and Co. Inc. - Segment focus
Exhibit 357: SWOT
Exhibit 358: Mitsubishi Tanabe Pharma Corp. - Overview
Exhibit 359: Mitsubishi Tanabe Pharma Corp. - Product / Service
Exhibit 360: Mitsubishi Tanabe Pharma Corp. - Key offerings
Exhibit 361: SWOT
Exhibit 362: Moderna Inc. - Overview
Exhibit 363: Moderna Inc. - Product / Service
Exhibit 364: Moderna Inc. - Key offerings
Exhibit 365: SWOT
Exhibit 366: Pfizer Inc. - Overview
Exhibit 367: Pfizer Inc. - Business segments
Exhibit 368: Pfizer Inc. - Key news
Exhibit 369: Pfizer Inc. - Key offerings
Exhibit 370: Pfizer Inc. - Segment focus
Exhibit 371: SWOT
Exhibit 372: Sanofi SA - Overview
Exhibit 373: Sanofi SA - Business segments
Exhibit 374: Sanofi SA - Key news
Exhibit 375: Sanofi SA - Key offerings
Exhibit 376: Sanofi SA - Segment focus
Exhibit 377: SWOT
Exhibit 378: Sinopharm - Overview
Exhibit 379: Sinopharm - Product / Service
Exhibit 380: Sinopharm - Key offerings
Exhibit 381: SWOT
Exhibit 382: Takeda Pharmaceutical Ltd. - Overview
Exhibit 383: Takeda Pharmaceutical Ltd. - Business segments
Exhibit 384: Takeda Pharmaceutical Ltd. - Key news
Exhibit 385: Takeda Pharmaceutical Ltd. - Key offerings
Exhibit 386: Takeda Pharmaceutical Ltd. - Segment focus
Exhibit 387: SWOT
Exhibit 388: Inclusions checklist
Exhibit 389: Exclusions checklist
Exhibit 390: Currency conversion rates for US$
Exhibit 391: Research methodology
Exhibit 392: Information sources
Exhibit 393: Data validation
Exhibit 394: Validation techniques employed for market sizing
Exhibit 395: Data synthesis
Exhibit 396: 360 degree market analysis
Exhibit 397: List of abbreviations
Executive Summary
The following companies are recognized as the key players in the global global vaccines market: AstraZeneca Plc, Bavarian Nordic AS, Bharat Biotech Ltd., BioKangtai, Biological E. Ltd., BioNTech SE, CSL Seqirus, Dynavax Technologies Corp., Emergent BioSolutions Inc., GC Biopharma Corp., GlaxoSmithKline Plc, Inovio Pharmaceuticals Inc., Johnson and Johnson, Merck and Co. Inc., Mitsubishi Tanabe Pharma Corp., Moderna Inc., Novavax Inc., Pfizer Inc., Sanofi SA, Serum Institute of India Ltd., Sinopharm, Takeda Pharmaceutical Ltd., Valneva SE.Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is accelerated adoption of ai in vaccine design and antigen selection."
According to the report, one of the major drivers for this market is the expansion of public health initiatives and national immunization programs.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AstraZeneca Plc
- Bavarian Nordic AS
- Bharat Biotech Ltd.
- BioKangtai
- Biological E. Ltd.
- BioNTech SE
- CSL Seqirus
- Dynavax Technologies Corp.
- Emergent BioSolutions Inc.
- GC Biopharma Corp.
- GlaxoSmithKline Plc
- Inovio Pharmaceuticals Inc.
- Johnson and Johnson
- Merck and Co. Inc.
- Mitsubishi Tanabe Pharma Corp.
- Moderna Inc.
- Novavax Inc.
- Pfizer Inc.
- Sanofi SA
- Serum Institute of India Ltd.
- Sinopharm
- Takeda Pharmaceutical Ltd.
- Valneva SE
